Latanoprost/Timolol Stada

Latanoprost, the active ingredient in Latanoprost/Timolol Stada, is a prostaglandin analog and non‑selective beta‑blocker presented as an ophthalmic solution for ocular use. It is indicated for the management of primary open‑angle glaucoma and ocular hypertension in adult patients.

GNH USA supplies Latanoprost/Timolol Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost/Timolol is used in the treatment of glaucoma and ocular hypertension, conditions characterized by elevated intraocular pressure. - Primary open‑angle glaucoma: reduces intraocular pressure to slow optic nerve damage. - Ocular hypertension: lowers eye pressure to prevent progression to glaucoma. - Secondary glaucoma (e.g., pseudoexfoliative): helps control pressure when monotherapy is insufficient.

The ocular combination may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Eye irritation: transient burning or stinging after instillation. - Conjunctival hyperemia: mild redness of the eye. - Eyelash changes: increased length or darkness. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Persistent ocular inflammation: uveitis or keratitis. - Systemic bradycardia: unusually slow heart rate.

Before prescribing Latanoprost/Timolol, clinicians should consider several safety and handling precautions. - Cardiovascular disease: avoid in patients with severe bradycardia or heart block. - Respiratory conditions: use cautiously in asthma or chronic obstructive pulmonary disease. - Pregnancy and lactation: safety not established; prescribe only if benefit outweighs risk. - Contact lens wearers: discontinue lenses before instillation and wait several minutes before reinserting. - Drug interactions: review concomitant β‑blockers or other intraocular pressure‑lowering agents. - Store at room temperature: keep below 25 °C, protect from light and moisture in the original container.

Latanoprost/Timolol may interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Systemic β‑blockers: additive bradycardia or hypotension. - Calcium channel blockers: increased risk of heart block. - Anticholinergic eye drops: reduced timolol effect.

Moderate Interactions (Monitor Closely): - MAO inhibitors: possible enhanced ocular hypotensive effect. - Other prostaglandin analogs: risk of excessive ocular inflammation. - NSAID eye drops: may increase irritation.